COMBINATION HORMONOTHERAPY WITH TAMOXIFEN AND FLUOXYMESTERONE IN PATIENTS WITH ADVANCED BREAST-CANCER RELAPSING ON HORMONOTHERAPY

被引：0
|
作者：
LEUENBERGER, U
GOLDHIRSCH, A
CAVALLI, F
RYSSEL, HJ
SONNTAG, RW
JOSS, RA
BRUNNER, KW
机构：
[1] OSPED SAN GIOVANNI,BELLINZONA,SWITZERLAND
[2] INSELSPITAL,INST MED ONCOL,CH-3010 BERN,SWITZERLAND
来源：
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1981年 / 17卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：943 / 943
页数：1
相关论文
共 50 条
  • [21] TAMOXIFEN AND FLUOXYMESTERONE IN ADVANCED BREAST-CANCER - A CONTROLLED CLINICAL-TRIAL
    WESTERBERG, H
    CANCER TREATMENT REPORTS, 1980, 64 (01): : 117 - 121
  • [22] THYMIDINE KINASE AS A PREDICTOR OF RESPONSE TO CHEMOTHERAPY OR HORMONOTHERAPY IN BREAST-CANCER
    BENNINI, N
    MAURIAC, L
    WAFFLART, J
    BONICHON, F
    DURAND, M
    BULLETIN DU CANCER, 1992, 79 (08) : 773 - 779
  • [23] TREATMENT OF PRIMARY BREAST-CANCER IN ELDERLY WOMEN - USEFULNESS OF HORMONOTHERAPY
    AUCLERC, G
    WEIL, M
    BOREL, C
    KHAYAT, D
    PRESSE MEDICALE, 1992, 21 (34): : 1631 - 1635
  • [24] CONTROVERSIES IN THE USE OF ADJUVANT CHEMOTHERAPY, HORMONOTHERAPY AND RADIOTHERAPY FOR BREAST-CANCER
    DONEGAN, WL
    CANADIAN JOURNAL OF SURGERY, 1992, 35 (04) : 371 - 377
  • [25] HORMONO-CHEMOTHERAPY VERSUS HORMONOTHERAPY (HT) FOLLOWED BY CHEMOTHERAPY (CT) IN ADVANCED BREAST-CANCER
    CAVALLI, F
    JUNGI, F
    MARTZ, G
    ALBERTO, P
    BRUNNER, K
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 406 - 406
  • [26] Second line hormonotherapy for breast cancer
    Platinsky, LV
    Sokolov, YN
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 200 - 201
  • [27] Hormonotherapy in breast cancer with bone metastasis
    Leriche, N
    Bonneterre, J
    BULLETIN DU CANCER, 1997, 84 (09) : 891 - 894
  • [28] COMBINATION OF TAMOXIFEN AND LEVODOPA IN ADVANCED BREAST-CANCER
    MUNDIA, AG
    KWEE, JPG
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 400 - 400
  • [29] REEVALUATION OF THE INDICATIONS OF ADJUVANT HORMONOTHERAPY IN HIGH-RISK PRIMARY BREAST-CANCER PATIENTS
    MARTIN, PM
    ROMAIN, S
    SPYRATOS, F
    SPITALIER, JM
    AYME, Y
    BRANDONE, H
    BRESSAC, C
    HANS, D
    JACQUEMIER, J
    HACENE, K
    BRUNET, M
    AMALRIC, R
    BULLETIN DU CANCER, 1991, 78 (08) : 709 - 723
  • [30] HORMONOTHERAPY OF METASTATIC BREAST-CANCER BY TAMOXIFEN AND MEDROXYPROGESTERONE ACETATE - RANDOMIZED TRIAL COMPARING ALTERNATING SEQUENCES WITH SUCCESSIVE APPLICATIONS
    MAURIAC, L
    DURAND, M
    BONICHON, F
    CHAUVERGNE, J
    BULLETIN DU CANCER, 1986, 73 (02) : 148 - 154
12345